aOR	Adjusted odds ratio
AST	Antimicrobial susceptibility testing
AUC	Area under the curve
BSI	Bloodstream infection
CI	Confidence interval
CP-KP	Carbapenemase-producing K. pneumoniae
CRE	Carbapenem-resistant Enterobacterales
CRKP	Carbapenem-resistant K. pneumoniae
CSKP	Carbapenem-susceptible K. pneumoniae
ESBL	Extended-spectrum beta-lactamase
EPV	Events per variable
EUCAST	European Committee on Antimicrobial Susceptibility Testing
ICU	Intensive care unit
IMP	Imipenemase metallo-beta-lactamase
IQR	Interquartile range
KPC	K. pneumoniae carbapenemase
MBL	Metallo-beta-lactamase
MDR	Multidrug-resistant
MIC	Minimum inhibitory concentration
NDM	New Delhi metallo-beta-lactamase
OR	Odds ratio
OXA-48-like	Oxacillinase-48-like carbapenemase
PCR	Polymerase chain reaction
PK/PD	Pharmacokinetic/pharmacodynamic
qSOFA	Quick Sequential Organ Failure Assessment
ROC	Receiver operating characteristic
RR	Risk ratio
SIR	Susceptible/increased exposure/resistant interpretation
SOFA	Sequential Organ Failure Assessment
TMP-SMX	Trimethoprim-sulfamethoxazole
UTI	Urinary tract infection
VAP	Ventilator-associated pneumonia
VIM	Verona integron-encoded metallo-beta-lactamase
XDR	Extensively drug-resistant